Identification of a subversive substrate of Trichomonas vaginalis purine nucleoside phosphorylase and the crystal structure of the enzyme-substrate complex

被引:18
|
作者
Zang, Y
Wang, WH
Wu, SW
Ealick, SE
Wang, CC [1 ]
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
[2] Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA
关键词
D O I
10.1074/jbc.M501843200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Trichomonas vaginalis is an anaerobic protozoan parasite that causes trichomoniasis, a common sexually transmitted disease with worldwide impact. One of the pivotal enzymes in its purine salvage pathway, purine nucleoside phosphorylase (PNP), shows physical properties and substrate specificities similar to those of the high molecular mass bacterial PNPs but differing from those of human PNP. While carrying out studies to identify inhibitors of T. vaginalis PNP (TvPNP), we discovered that the nontoxic nucleoside analogue 2-fluoro-2'-deoxyadenosine (F-dAdo) is a "subversive substrate." Phosphorolysis by TvPNP of F-dAdo, which is not a substrate for human PNP, releases highly cytotoxic 2-fluoroadenine (F-Ade). In vitro studies showed that both F-dAdo and F-Ade exert strong inhibition of T. vaginalis growth with estimated IC50 values of 106 and 84 nM, respectively, suggesting that F-dAdo might be useful as a potential chemotherapeutic agent against T. vaginalis. To understand the basis of TvPNP specificity, the structures of TvPNP complexed with F-dAdo, 2-fluoroadenosine, formycin A, adenosine, inosine, or 2'-deoxyinosine were determined by x-ray crystallography with resolutions ranging from 2.4 to 2.9 . These studies showed that the quaternary structure, monomer fold, and active site are similar to those of Escherichia coli PNP. The principal active site difference is at Thr-156, which is alanine in E. coli PNP. In the complex of TvPNP with F-dAdo, Thr-156 causes the purine base to tilt and shift by 0.5 as compared with the binding scheme of F-dAdo in E. coli PNP. The structures of the TvPNP complexes suggest opportunities for further improved subversive substrates beyond F-dAdo.
引用
收藏
页码:22318 / 22325
页数:8
相关论文
共 50 条
  • [1] The purine nucleoside phosphorylase from Trichomonas vaginalis is a homologue of the bacterial enzyme
    Munagala, N
    Wang, CC
    BIOCHEMISTRY, 2002, 41 (33) : 10382 - 10389
  • [2] SPECTROPHOTOMETRIC STUDY OF ENZYME-SUBSTRATE COMPLEX OF PHOSPHORYLASE B
    BRESLER, S
    FIRSOV, L
    JOURNAL OF MOLECULAR BIOLOGY, 1968, 35 (01) : 131 - &
  • [3] ADENINE AS SUBSTRATE FOR PURINE NUCLEOSIDE PHOSPHORYLASE
    ZIMMERMAN, TP
    GERSTEN, NB
    ROSS, AF
    MIECH, RP
    CANADIAN JOURNAL OF BIOCHEMISTRY, 1971, 49 (09): : 1050 - +
  • [4] Inhibition and structure of Trichomonas vaginalis purine nucleoside phosphorylase with picomolar transition state analogues
    Rinaldo-Matthis, Agnes
    Wing, Corin
    Ghanem, Mahmoud
    Deng, Hua
    Wu, Peng
    Gupta, Arti
    Tyler, Peter C.
    Evans, Gary B.
    Furneaux, Richard H.
    Almo, Steven C.
    Wang, Ching C.
    Schramm, Vern L.
    BIOCHEMISTRY, 2007, 46 (03) : 659 - 668
  • [5] THE ENZYME-SUBSTRATE COMPLEX
    FRIEDEN, E
    SCIENTIFIC AMERICAN, 1959, 201 (02) : 119 - &
  • [6] ISOLATION OF ENZYME-SUBSTRATE COMPLEX
    YAGI, K
    SEIKAGAKU, 1974, 46 (09): : 747 - 757
  • [7] SUBSTRATE/INHIBITOR PROPERTIES OF TUMOR PURINE NUCLEOSIDE PHOSPHORYLASE
    BZOWSKA, A
    POGOSJAN, L
    ANANIEV, AV
    KULIKOWSKA, E
    SHUGAR, D
    NUCLEOSIDES & NUCLEOTIDES, 1995, 14 (3-5): : 517 - 520
  • [8] Enzyme-substrate interactions in the purine-specific nucleoside hydrolase from Trypanosoma vivax
    Versées, W
    Decanniere, K
    Van Holsbeke, E
    Devroede, N
    Steyaert, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (18) : 15938 - 15946
  • [9] The use of Trichomonas vaginalis purine nucleoside phosphorylase to activate fludarabine in the treatment of solid tumors
    William B. Parker
    Paula W. Allan
    William R. Waud
    Jeong Hong
    Melissa Gilbert-Ross
    B. R. Achyut
    Disha Joshi
    Turang Behbahani
    Regina Rab
    Steven E. Ealick
    Eric J. Sorscher
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 573 - 583
  • [10] The use of Trichomonas vaginalis purine nucleoside phosphorylase to activate fludarabine in the treatment of solid tumors
    Parker, William B.
    Allan, Paula W.
    Waud, William R.
    Hong, Jeong
    Gilbert-Ross, Melissa
    Achyut, B. R.
    Joshi, Disha
    Behbahani, Turang
    Rab, Regina
    Ealick, Steven E.
    Sorscher, Eric J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (03) : 573 - 583